SEC Form 4 · accession 0001493152-26-043996
Grace Therapeutics, Inc. · GRCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Opaleye Management Inc.
10% Owner
Period of report
Sep 21, 2026
Accepted (ET)
Sep 23, 2026 · 6:19 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001444192
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per shareF1,F2 | Sep 21, 2026 | P | 9,771 | $2.10 | A | 2,850,000 | I | By Opaleye, L.P. |
| Common Stock, par value $0.0001 per shareF1,F2 | Sep 23, 2026 | P | 5,318 | $2.10 | A | 2,855,318 | I | By Opaleye, L.P. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management, Inc. may be deemed to beneficially own the securities owned directly by the Fund.
- F2Opaleye Management, Inc. disclaims beneficial ownership of the shares reported herein except to the extent of its pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that Opaleye Management, Inc. is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or for any other purpose.